1. CollinsK, ChenB, KalamsS, WalkerB, BaltimoreD (1998) HIV-1 Nef protein protects infected primary human cells from killing by cytotoxic T lymphocytes. Nature 391: 397–401.
2. SchwartzO, MarechalV, Le GallS, LemonnierF, HeardJM (1996) Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2: 338–342.
3. RoethJF, WilliamsM, KasperMR, FilzenTM, CollinsKL (2004) HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail. J Cell Biol 167: 903–913.
4. Le GallS, ErdtmannL, BenichouS, Berlloz-TorrentC, LiuL, et al. (1998) Nef interacts with mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8: 483–495.
5. WonderlichER, WilliamsM, CollinsKL (2008) The tyrosine binding pocket in the adaptor protein 1 (AP-1) mu1 subunit is necessary for Nef to recruit AP-1 to the major histocompatibility complex class I cytoplasmic tail. J Biol Chem 283: 3011–3022.
6. JiaX, SinghR, HomannS, YangH, GuatelliJ, et al. (2012) Structural basis of evasion of cellular adaptive immunity by HIV-1 Nef. Nat Struct Mol Biol 19: 701–706.
7. KulpaDA, Del CidN, PetersonKA, CollinsKL (2013) Adaptor protein 1 promotes cross-presentation through the same tyrosine signal in major histocompatibility complex class I as that targeted by HIV-1. J Virol 87: 8085–8098.
8. WonderlichER, LeonardJA, CollinsKL (2011) HIV immune evasion disruption of antigen presentation by the HIV Nef protein. Adv Virus Res 80: 103–127.
9. LeonardJA, FilzenT, CarterCC, SchaeferM, CollinsKL (2011) HIV-1 Nef disrupts intracellular trafficking of major histocompatibility complex class I, CD4, CD8, and CD28 by distinct pathways that share common elements. J Virol 85: 6867–6881.
10. LamaJ, MangasarianA, TronoD (1999) Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr Biol 9: 622–631.
11. RossTM, OranAE, CullenBR (1999) Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr Biol 9: 613–621.
12. SheehyAM, GaddisNC, ChoiJD, MalimMH (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418: 646–650.
13. MalimMH (2009) APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos Trans R Soc Lond B Biol Sci 364: 675–687.
14. NormanJM, MashibaM, McNamaraLA, Onafuwa-NugaA, Chiari-FortE, et al. (2011) The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells. Nature immunology 12: 975–983.
15. YuX, YuY, LiuB, LuoK, KongW, et al. (2003) Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302: 1056–1060.
16. ZhangW, DuJ, EvansSL, YuY, YuXF (2012) T-cell differentiation factor CBF-beta regulates HIV-1 Vif-mediated evasion of host restriction. Nature 481: 376–379.
17. JagerS, KimDY, HultquistJF, ShindoK, LaRueRS, et al. (2012) Vif hijacks CBF-beta to degrade APOBEC3G and promote HIV-1 infection. Nature 481: 371–375.
18. ComptonAA, HirschVM, EmermanM (2012) The host restriction factor APOBEC3G and retroviral Vif protein coevolve due to ongoing genetic conflict. Cell Host Microbe 11: 91–98.
19. NeilSJ, ZangT, BieniaszPD (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451: 425–430.
20. Van DammeN, GoffD, KatsuraC, JorgensonRL, MitchellR, et al. (2008) The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3: 245–252.
21. HarrisRS, HultquistJF, EvansDT (2012) The restriction factors of human immunodeficiency virus. J Biol Chem 287: 40875–40883.
22. MargottinF, BourSP, DurandH, SeligL, BenichouS, et al. (1998) A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol Cell 1: 565–574.
23. HotterD, SauterD, KirchhoffF (2013) Emerging Role of the Host Restriction Factor Tetherin in Viral Immune Sensing. J Mol Biol 425: 4956–4964.
24. RomaniB, CohenEA (2012) Lentivirus Vpr and Vpx accessory proteins usurp the cullin4-DDB1 (DCAF1) E3 ubiquitin ligase. Curr Opin Virol 2: 755–763.
25. SchrofelbauerB, YuQ, ZeitlinSG, LandauNR (2005) Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases. J Virol 79: 10978–10987.
26. MashibaM, CollinsKL (2013) Molecular mechanisms of HIV immune evasion of the innate immune response in myeloid cells. Viruses 5: 1–14.
27. LaguetteN, SobhianB, CasartelliN, RingeardM, Chable-BessiaC, et al. (2011) SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474: 654–657.
28. LahouassaH, DaddachaW, HofmannH, AyindeD, LogueEC, et al. (2012) SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 13: 223–228.
29. FregosoOI, AhnJ, WangC, MehrensJ, SkowronskiJ, et al. (2013) Evolutionary toggling of Vpx/Vpr specificity results in divergent recognition of the restriction factor SAMHD1. PLoS Pathog 9: e1003496 doi:10.1371/journal.ppat.1003496
30. KellyBT, McCoyAJ, SpateK, MillerSE, EvansPR, et al. (2008) A structural explanation for the binding of endocytic dileucine motifs by the AP2 complex. Nature 456: 976–979.